Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001209191-17-039319

Options or other derivatives

  • Director acquired 121,483 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
SANDAGE BOBBY W. JR., PHD. Director 2017-06-09 Grant or award · Stock Option (Right to Buy) +121,483 121,483 D: show line 1 in the form
Loading xslF345X03/doc4.xml…